Senior Leadership

John Pinney

Founder and Chief Executive Officer

Joe Gitchell


Lucy Owen

Senior Vice President

Judy Ashworth, M.D.

Vice President, Rx Strategic Services and Chief Medical Officer

Jack Henningfield, Ph.D.

Vice President, Research, Health Policy, and Abuse Liability

Saul Shiffman, Ph.D.

Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis

Bernie Simone

Vice President, Client Strategy and Rx-to-OTC Switch

George Quesnelle

Senior Strategic Advisor, OTC Commercialization and Optimization

Sidney Schnoll, M.D., Ph.D.

Vice President, Pharmaceutical Risk Management


August Buchhalter, Ph.D.

Director, Abuse Potential Assessment

Marion A. Coe, Ph.D.

Director, Clinical Development and Post-Marketing Surveillance

Michelle Ertischek, MPH

Director, Planning and Operations

Robyn Gougelet

Director, Health Policy and Regulatory Strategy

Ryan Lanier, Ph.D.

Director, Clinical Development and Abuse Liability

Mark Sembower, MS

Director, Data Management and Statistical Analysis

Christine Sweeney, Ph.D., MPH

Director, Issues Management

Daniel Wang

Director, Cannabinoids and New Dietary Ingredients

Lisa Zapawa, M.D., MPH

Director, Medical Science

Scientists & Associates

Rachel Beck, Ph.D.


Gina Bittner

Senior Associate

Floe Foxon

Data Analyst

Yolanda Green

Senior Associate

Michael Hannon, MA

Data Analyst

Sooyong Kim, MD, MPH


Erin Nealer


Steve Pype

Senior Data Manager

Sarah Scholl, MPH

Senior Associate

Arielle Selya, PhD


Operational & Support Staff

Gabrielle Blythe

Meeting Coordinator and Executive Assistant

Steve Choi

Director of Finance

Kirk McKay

Executive Assistant

Science & Policy Advisors

Edward Cone, Ph.D.

Drug Delivery and Abuse Deterrent Drug Products

Marilyn A. Huestis, Ph.D.

Clinical Pharmacology and Toxicology, Cannabinoid Pharmacotherapies

Karen L. Sees, D.O.

Drug Development and Pharmacovigilance